Nykode Therapeutics AS
Cena
Finančné výkazy zatiaľ nemáme
Firma vykazuje v mene USD, cena titulu je v mene NOK. Výkazy zatiaľ neprevádzame medzi menami, pretože by z nich násobky (P/E, P/S a ďalšie) vychádzali nesprávne, a preto ich tu neukazujeme. Cenu a jej vývoj vidíte vyššie.
Fundamenty
Načítavam kľúčové čísla…
Insideri, analytici a ľudia
Všetky obchody a zmenyNačítavam insiderov, analytikov a názory…
Co se právě děje
AI souhrnO spoločnosti
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include ABI-SUVA for targeting HPV16+ induced malignancies, with head, and neck cancer as the primary indication is in Phase 2 randomized controlled trial. It also offers VB10.NEO, which is in Phase1b VB-N-02 trial; technology platform, which combines genes with desired properties to make novel compounds by creating a new code. Nykode Therapeutics AS was founded in 2006 and is headquartered in Oslo, Norway.
Český popis pripravujeme.
- Web
- nykode.com
- Zamestnanci
- 59
- Krajina
- Norsko
- Dáta od
- 7. 10. 2020